Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg

Glibenclamide, Pioglitazone + Metformin Hydrochloride ER 5mg+15mg+500mg Tablets Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg
  

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• a) Glibenclamide, Pioglitazone + Metformin Hydrochloride Extended-Release Tablets 5mg+15mg+500mg
  Each bilayer Un-coated tablet contains:
  Glibenclamide IP………………………….…….5mg
  Pioglitazone Hydrochloride IP
  Equivalent to Pioglitazone ……………………15mg
  Metformin Hydrochloride IP………………….500mg
  (In extended-release form)
  Excipients……………………………………………q.s.
  Colours: Iron oxide Red

THERAPEUTIC INDICATIONS:

• Treatment of type 2 diabetes in adults, as replacement for previous combination therapy with metformin and glibenclamide in patients whose glycaemia is stable and well-controlled.

CAUTION & WARNING:

• CAUTION:
  Read enclosed leaflet before use.
  Keep medicine out of reach of children.
  SWALLOW WHOLE DO NOT CRUSH
• SCHEDULE “H” Prescription Drug –Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
  

STORAGE & DOSAGE:

• Storage: Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.
• Dosage:As directed by the Physician.

Introduction to Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg

Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg are a powerful triple-combination medication widely prescribed for the effective management of Type 2 Diabetes Mellitus. Each component plays a critical role in controlling blood glucose levels:

• Glibenclamide: Stimulates pancreatic beta cells to release more insulin.

• Pioglitazone: Improves insulin sensitivity in muscle and adipose tissue.

• Metformin Hydrochloride ER: Reduces hepatic glucose production while enhancing insulin sensitivity.

This combination therapy is ideal for patients who fail to achieve glycemic control with monotherapy or dual therapy. Globally, the demand for this formulation has increased significantly due to the rising prevalence of diabetes and the effectiveness of multi-drug therapy.

As one of the leading Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg manufacturers in India, Taj Pharma has emerged as the preferred partner for importers, distributors, and healthcare providers across 40+ countries.

Why Importers, Exporters, and Buyers Choose Taj Pharma?

When it comes to Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg export from India, Taj Pharma delivers unmatched expertise, quality, and compliance.

1. Regulatory Documentation Provided

Taj Pharma provides a complete set of regulatory documents required for international approvals, including:

• WHO-GMP Certificate

• EU-GMP compliance (where applicable)

• Certificate of Pharmaceutical Product (COPP)

• CTD/ACTD Dossiers

• Free Sale Certificate (FSC)

• Certificate of Analysis (CoA)

2. Custom Packaging & Labeling

• Blister packs, bottles, or alu-alu packaging based on buyer’s market needs.

• Multilingual labeling (Arabic, French, Spanish, Russian, etc.) for global compliance.

• Tamper-proof, export-grade packaging ensuring product stability during long shipments.

3. Shelf-life, Storage & Dosage Form

• Shelf Life: 24–36 months depending on storage conditions.

• Storage: Store in a cool, dry place below 25°C, away from moisture.

• Dosage Form: Extended-Release (ER) Tablets.

4. Target Countries & Export Markets

Taj Pharma supplies Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg across Africa, Latin America, Asia, CIS, and the Middle East. Key markets include:

• Nigeria, Kenya, Ghana, South Africa

• Vietnam, Philippines, Myanmar

• UAE, Saudi Arabia, Yemen, Iraq

• Russia, Ukraine, Kazakhstan

• Peru, Chile, Bolivia

Why is the Most Trusted Manufacturer, Supplier, and Exporter

Taj Pharma has built a strong reputation as the top Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg manufacturer in India because of its quality-driven, affordable, and global-first approach.

1. State-of-the-Art Manufacturing

• WHO-GMP & ISO 9001:2015 certified facilities in Vapi, Gujarat.

• Dedicated diabetes care production lines.

• Automated systems ensuring zero contamination and precision dosing.

2. Affordable Pricing & Quality Assurance

• Competitive pricing for global buyers without compromising on quality.

• Each batch undergoes stability testing, dissolution profiling, and bioequivalence studies.

3. Global Presence & Supply Chain Support

• Robust export network covering 50+ countries.

• Experienced regulatory and logistics teams handling registrations and product launch support.

• Flexible MOQs (Minimum Order Quantities) catering to both large distributors and smaller markets.

4. Top 20 Countries Exporting

Taj Pharma exports Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg to:

Nigeria, Kenya, South Africa, Vietnam, Philippines, Iraq, Libya, Uzbekistan, Ghana, Ethiopia, Yemen, Tanzania, Sri Lanka, Afghanistan, Myanmar, Nepal, Kazakhstan, Ecuador, Bangladesh, Dominican Republic

Technical Product Specification

If you are an importer, distributor, or healthcare buyer looking for a trusted Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg manufacturer in India, Taj Pharma is your ideal partner.

📞 Contact Taj Pharma Today to get competitive quotations, regulatory support, and assured global supply of high-quality formulations.

👉 Visit: www.tajpharma.com | ✉ Email: info@tajpharma.com

Top 20 FAQs 

Q1: What is Glibenclamide, Pioglitazone + Metformin Hydrochloride ER Tablets 5mg+15mg+500mg used for?
A1: It is used to manage Type 2 Diabetes Mellitus when single or dual therapy fails.

Q2: Who manufactures these tablets in India?
A2: Taj Pharma is a leading WHO-GMP certified manufacturer from Vapi, Gujarat, India.

Q3: Are these tablets safe for long-term use?
A3: Yes, they are generally safe under medical supervision, though regular monitoring is advised.

Q4: What are the side effects of this combination?
A4: Possible effects include hypoglycemia, weight gain, edema, and rare liver-related issues.

Q5: What certifications does Taj Pharma hold?
A5: WHO-GMP, EU-GMP, COPP, and ISO certifications.

Q6: Can importers request custom packaging?
A6: Yes, Taj Pharma offers customized packaging & multilingual labeling.

Q7: What is the minimum order quantity (MOQ)?
A7: MOQ is flexible depending on buyer requirements.

Q8: Which regions does Taj Pharma export to?
A8: Africa, Latin America, Middle East, Asia, and CIS countries.

Q9: How is the medicine stored?
A9: Store below 25°C in a dry, cool environment.

Q10: Can elderly patients use it?
A10: Yes, but those over 65 should be closely monitored for heart-related risks.

Q11: Does it require a prescription?
A11: Yes, it is a prescription-only medication.

Q12: How often is it taken?
A12: Once or twice daily, as prescribed by a doctor.

Q13: What is the shelf life?
A13: 24–36 months.

Q14: Does Taj Pharma provide regulatory dossiers?
A14: Yes, CTD/ACTD dossiers are available.

Q15: Is lactic acidosis a risk?
A15: Rarely, due to metformin, especially in kidney or liver-compromised patients.

Q16: Can it be combined with insulin?
A16: Only if prescribed by a healthcare professional.

Q17: What strength is available?
A17: 5mg + 15mg + 500mg.

Q18: How is Taj Pharma different from other manufacturers?
A18: Global presence, stringent quality, affordable pricing, and 20+ years of expertise.

Q19: Does Taj Pharma support product registration abroad?
A19: Yes, with complete documentation and regulatory support.

Q20: How to order?
A20: Contact Taj Pharma via website or email for quotations and supply details.